文献速递中医内科中药与中成药合理使用

中药复方治疗幽门螺杆菌阳性消化性溃疡的贝叶斯网络Meta分析

Evidence construction of Chinese herbal formulae for the treatment of H. pylori positive peptic ulcer: A Bayesian network Meta-analysis.
PubMed 文献 · Phytomedicine · 2022-07-17

结果显示联合中药可显著提高根除率、临床有效率并降低复发率,其中常规三联联合香砂六君子汤综合疗效最优。

要点

  • 中药复方联合常规三联疗法可提高H. pylori根除率与临床有效率。
  • 联合治疗可降低复发率,且安全性较好。

核心结论

  • 中药复方联合常规三联疗法治疗H. pylori阳性消化性溃疡的疗效与安全性得到验证。
  • 常规三联联合香砂六君子汤可能是最满意的治疗策略。

研究设计与样本

  • 贝叶斯网络Meta分析,检索PubMed、Embase、Cochrane Library、Web of Science及四个中文数据库的RCT。

主要发现

  • 与单用常规三联疗法相比,联合中药复方可显著提高H. pylori根除率、临床有效率并降低复发率,且方式相对安全。

关键数值与推荐

  • 主要结局指标为H. pylori根除率;次要结局指标为临床有效率、复发率和不良反应报告。

临床怎么用

  • 临床可考虑在常规三联疗法基础上联合中药复方(如香砂六君子汤)以提高H. pylori阳性消化性溃疡的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Helicobacter pylori (H. pylori) positive peptic ulcer disease (PUD) is a highly prevalent digestive disease with serious consequences of poor prognosis without rational medical intervention. Apparent advantages of Chinese herbal formulae application in PUDs have been appreciated by clinical practitioners recently in China. However, there is no enough viewpoint of evidence-based medicine for them to reach a broad consensus at the more favorable formulae. Therefore, we adopted the method of Bayesian network Meta-analysis (BNMA) in order to get a solution. METHOD: Literature retrieval of clinical randomized controlled trials (RCTs) was conducted with eight databases of PubMed, Embase, Cochrane Library, Web of Science, Chinese National Knowledge Infrastructure, the VIP medicine information system, the Wanfang Data Knowledge Service Platform and Chinese Biomedical Literature Service System. Review Manager 5.4 software, R project 4.1.1 software and STATA16.0 software were used to carry out this BNMA. The primary outcome indicator is H. pylori eradicated rate. The secondary outcome indicator is clinical effectiveness rate, recurrence rate and adverse reaction report. RESULT: A total of fifty-one RCTs involving 5172 patients and ten therapeutic strategies were included in this BNMA. The results showed that supplementation with Chinese herbal formulae significantly improved the eradication rate, clinical efficiency and reduced recurrence rate of H. pylori compared with the single conventional triple therapy (CON) group in a relatively safe manner. Comprehensive therapeutic efficacy analysis of H. pylori eradicated rate and clinical effectiveness rate showed that CON combined with Xiangsha Liujunzi decoction (XSD) manifests at the first grade among these ten therapeutic strategies. CONCLUSION: The efficacy and safety of Chinese herbal formulae and conventional triple therapy were validated by this BNMA. CON+XSD appears to be the most satisfactory therapeutic strategy for H. pylori-positive PUD, reminding clinicians of the potential value of the combination of Chinese herbal formulae and conventional chemotherapy. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42021268574.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Yang J, Yang H, Dai Y, et al. Evidence construction of Chinese herbal formulae for the treatment of H. pylori positive peptic ulcer: A Bayesian network Meta-analysis. Phytomedicine. 2022. PMID: 35905565. doi:10.1016/j.phymed.2022.154327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。